⌘K

Login Start Free

Home/Filings/4/0001171843-13-001270

4//SEC Filing

Viallet Jean 4

Accession 0001171843-13-001270

CIK 0001318641other

View on SEC.gov Company Profile

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 8:47 PM ET

Size

5.2 KB

Accession

0001171843-13-001270

Insider Transaction Report

Form 4

Period: 2013-04-03

CLEVELAND BIOLABS INCCBLI

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2013-04-03+100,000→ 100,000 total
Exercise: $2.04Exp: 2023-04-03→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The option becomes exercisable in four equal installments on the following dates: April 4, 2013, April 1, 2014, April 1, 2015 and April 1, 2016. 25,000 shares underlying the option are currently exercisable.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1

filerCIK 0001573790

Filing Metadata

Form type: 4
Filed: Apr 4, 8:00 PM ET
Accepted: Apr 5, 8:47 PM ET
Size: 5.2 KB

View on SEC.gov